Page last updated: 2024-09-04

ertapenem and Pseudomonas Infections

ertapenem has been researched along with Pseudomonas Infections in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (26.32)29.6817
2010's13 (68.42)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV1
Bhattacharjee, A; Chakravarty, A; Chanda, DD; Paul, D1
Ha, DT; Ho-Le, TP; Hoang, HQ; Nguyen, DA; Nguyen, TA; Nguyen, TSM; Nguyen, TV; Pham, TTN; Tran, GM; Tran, NV; Tran-Nguyen, CH1
Abdul, W; Grigoriu, A; Smoke, SM; Vasant, D1
Block, CS; Cohen, MJ; Moses, AE; Nir-Paz, R1
Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL1
Lima, AL; Oliveira, PR; Paula, AP; Zumiotti, AV1
Dal-Paz, K; Lima, AL; Oliveira, PR; Paula, AP; Rossi, F; Zumiotti, AV1
Citron, DM; Elgourt, T; Goldstein, EJ; Lu, S; Meibohm, AR; Peraino, V1
Eagye, KJ; Nicolau, DP2
dos Santos, RP; Goldani, LZ; Jacoby, T1
Chen, CY; Huang, YB; Liao, FF1
Gastal, SL; Goldani, LZ; Gorniak Lovatto, C; Jacoby, T; Konkewicz, L; Kuplich, NM; Lisboa, T; Nagel, FM; Pires dos Santos, R; Pires Machado, D; Pires, MR1
Beović, B; Cizman, M; Kreft, S; Seme, K1
Cook, PP; Gooch, M; Rizzo, S1
Carmeli, Y; Crank, CW; Goff, DA; Goldstein, EJ; Graber, CJ; Lima, AL; Nicolau, DP1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, CM1
Baysallar, M; Doğanci, L; Kiliç, A; Küçükkaraaslan, A; Senses, Z1

Reviews

1 review(s) available for ertapenem and Pseudomonas Infections

ArticleYear
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections

2012

Other Studies

18 other study(ies) available for ertapenem and Pseudomonas Infections

ArticleYear
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States

2008
An insight into analysis and elimination of plasmids encoding metallo-β-lactamases in Pseudomonas aeruginosa.
    Journal of global antimicrobial resistance, 2020, Volume: 21

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cross Infection; DNA Copy Number Variations; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression Regulation, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Dodecyl Sulfate; Suppuration; Urine

2020
Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam.
    BMC infectious diseases, 2017, 06-15, Volume: 17, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Intensive Care Units; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Vietnam

2017
Effect of Carbapenem Selection on Drug Acquisition Costs and Carbapenem Resistance.
    Journal of pharmacy practice, 2019, Volume: 32, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States

2019
Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections

2014
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
    Biomedica : revista del Instituto Nacional de Salud, 2016, Feb-23, Volume: 36, Issue:0

    Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins

2016
Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Brazil; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Pseudomonas aeruginosa; Pseudomonas Infections

2008
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:5

    Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Formularies, Hospital as Topic; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sulbactam

2009
Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Hospitals; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Pseudomonas aeruginosa; Pseudomonas Infections; United States

2010
Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam

2010
Decrease in serum valproic acid levels during treatment with ertapenem.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Volume: 67, Issue:15

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cellulitis; Drug Antagonism; Ertapenem; Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Seizures; Staphylococcal Infections; Staphylococcus epidermidis; Valproic Acid

2010
Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Utilization; Ertapenem; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cross Infection; Ertapenem; Hand Disinfection; Hospitals, University; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis

2011
Does ertepenem alter the susceptibility of Pseudomonas aeruginosa to carbapenems?
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Interactions; Ertapenem; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; Formularies, Hospital as Topic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; North Carolina; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies

2011
KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2013
[Investigation of the in-vitro effectiveness of ertapenem against Pseudomonas aeruginosa strains isolated from intensive care unit patients].
    Mikrobiyoloji bulteni, 2004, Volume: 38, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intensive Care Units; Lactams; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2004